Objectives. Individual differences in proportion of stroma, epithelium, and luminal space components in benign prostatic hyperplasia (BPH) may explain the differences in clinical outcome of the patients treated with α- reductase inhibitors or α-blocking agents and other alternative treatments. Knowledge of the individual proportions of these elements may orient the clinician toward different therapeutic approaches. To determine whether a single prostate biopsy is representative of the whole adenoma, using quantitative morphometry, we have compared the percentage of smooth muscle cells and glandular cells in one prostate needle biopsy and in the corresponding prostate adenoma removed by open surgery. Methods. Quantification was made using a ...
Increased incidence of benign prostatic hyperplasia (BPH) has been associated with age of men. The q...
Introduction: Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are the most common disea...
From 1992 to 1993, the Scarpa Foundation Center of Pavia (SFCP) with 12 associated Italian Urologica...
Purpose: The negative correlation between BPH-size and incidence of prostate cancer (PCa) is well-do...
Objective: To investigate the adequacy of the samples obtained by prostate biopsies and the factors ...
ABSTRACTObjectives: To determine the histology of the prostate in prostatectomy done for benign pros...
What's known on the subject? and What does the study add? Much of our understanding of the pathologi...
Benign prostatic hyperplasia (BPH) is a nonmalignant pathological enlargement of the prostate, which...
OBJECTIVE: Preoperative determination of prostate cancer (PCa) tumor volume (TV) is still a big chal...
Aim: An accurate estimation of the degree of prostate volume (PV) enlargement is important for the c...
Prostatic lesions in Brazilian patients with benign prostatic hyperplasia (BPH, 26 cases) or adenoca...
Prostate cancer is the third most common cancer in men worldwide, and poses a challenge both for pat...
To determine the distribution characteristics of cancerous foci in the prostate by retrospective ana...
Introduction: The widespread use of the prostate specific antigen (PSA) has largely improved the ear...
Abstract  Benign prostatic hyperplasia (BPH) is one of the most common benign tumors in men with pr...
Increased incidence of benign prostatic hyperplasia (BPH) has been associated with age of men. The q...
Introduction: Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are the most common disea...
From 1992 to 1993, the Scarpa Foundation Center of Pavia (SFCP) with 12 associated Italian Urologica...
Purpose: The negative correlation between BPH-size and incidence of prostate cancer (PCa) is well-do...
Objective: To investigate the adequacy of the samples obtained by prostate biopsies and the factors ...
ABSTRACTObjectives: To determine the histology of the prostate in prostatectomy done for benign pros...
What's known on the subject? and What does the study add? Much of our understanding of the pathologi...
Benign prostatic hyperplasia (BPH) is a nonmalignant pathological enlargement of the prostate, which...
OBJECTIVE: Preoperative determination of prostate cancer (PCa) tumor volume (TV) is still a big chal...
Aim: An accurate estimation of the degree of prostate volume (PV) enlargement is important for the c...
Prostatic lesions in Brazilian patients with benign prostatic hyperplasia (BPH, 26 cases) or adenoca...
Prostate cancer is the third most common cancer in men worldwide, and poses a challenge both for pat...
To determine the distribution characteristics of cancerous foci in the prostate by retrospective ana...
Introduction: The widespread use of the prostate specific antigen (PSA) has largely improved the ear...
Abstract  Benign prostatic hyperplasia (BPH) is one of the most common benign tumors in men with pr...
Increased incidence of benign prostatic hyperplasia (BPH) has been associated with age of men. The q...
Introduction: Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are the most common disea...
From 1992 to 1993, the Scarpa Foundation Center of Pavia (SFCP) with 12 associated Italian Urologica...